Yes, because their early tests were so promising, MSK decided that one of the most promising anti-cancer drugs in history should be shared with 26 other institutions instead of kept at MSK where they could have taken all of the prestige. That's the ticket. Today's announcement is bullish for poster board sales and mice deaths only IMO. Stock price will lag into the ESOP set date May 1 and then hopefully the data will start to pump us up again like in 2012 leading to SUNRISE unblinding.